Projects per year
Personal profile
Research interests
Kamala is the senior researcher and senior lecturer committed to public health and tropical medicine and has more than 10 years of field experience in Africa and Asia, coordinating clinical trials to inform treatment of the management of infectious diseases.
Her current research at Menzies focuses on optimising the treatment of P. vivax and developing public health strategies for malaria elimination. Her research program spans clinical trials and epidemiological studies and incorporates related aspects of health economics and social science.
She has published in leading international journals such as PLOS Med and the Lancet.
Expertise related to UN Sustainable Development Goals
In 2015, UN member states agreed to 17 global Sustainable Development Goals (SDGs) to end poverty, protect the planet and ensure prosperity for all. This person’s work contributes towards the following SDG(s):
-
SDG 2 Zero Hunger -
SDG 3 Good Health and Well-being -
SDG 6 Clean Water and Sanitation -
SDG 8 Decent Work and Economic Growth -
SDG 9 Industry, Innovation, and Infrastructure -
SDG 10 Reduced Inequalities -
SDG 13 Climate Action -
SDG 16 Peace, Justice and Strong Institutions -
SDG 17 Partnerships for the Goals
Fingerprint
Dive into the research topics where Kamala Ley-Thriemer is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
Collaborations and top research areas from the last five years
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
-
EFFORT clinical trial: Effectiveness of tafenoquine and primaquine
Ley-Thriemer, K. (Principal Investigator/Chief Investigator A) & Cassidy-Seyoum, S. (Student Investigator)
16/08/21 → 26/06/25
Project: HDR Project › PhD
-
Evidence-based policy change for more effective radical cure
Ley-Thriemer, K. (Principal Investigator/Chief Investigator A) & Ruwanpura, V. S. H. (Student Investigator)
12/08/19 → 23/06/25
Project: HDR Project › PhD
-
Molecular Surveillance of Drug Resistant Malaria
Ley-Thriemer, K. (Principal Investigator/Chief Investigator A), Mon, N. C. N. (Associate Investigator) & Tun, M. W. (Associate Investigator)
1/07/15 → 30/05/16
Project: Research
-
Vivax malaria radical cure implementation, challenges, and the way forward in the case of South Ethiopia
Ley-Thriemer, K. (Principal Investigator/Chief Investigator A) & Degaga, T. S. (Student Investigator)
31/08/23 → …
Project: HDR Project › PhD
-
Clinical perspectives on hemoglobin measurement: The example of malaria radical cure
Chu, C. S., Brindle, E., Degaga, T. S., Duparc, S., Gerth-Guyette, E., Hsiang, M., Lacerda, M., Thriemer, K., Noviyanti, R., Pereira, D., Price, R., Robinson, L. J., Vidal-Cardenas, E., Yilma, D., Domingo, G. J. & Zobrist, S., Jun 2026, In: PLOS Global Public Health. 6, 6 June, p. 1-7 7 p., e0006614.Research output: Contribution to journal › Article › peer-review
Open AccessFile2 Downloads (Pure) -
Dissemination of EFFORT trial results in Indonesia: a stakeholder meeting report on tafenoquine and primaquine for radical cure of Plasmodium vivax
Pasaribu, A. P., Jimanto, V., Ainur, F., Saragih, N. R., Hadi, H., Siagian, D. S. P., Sinaga, B. J., Satyagraha, A. W., Laihad, F. J., Diptyanusa, A., Ubra, R. R., Tekege, O., Darmayanti, L., Herdiana, H., Adella, J., Mannion, K., Curry, E., Poespoprodjo, J. R., Kenangalem, E. & Burdam, F. H. & 19 others, , May 2026, In: Malaria Journal. 25, 1, p. 1-6 6 p., 227.Research output: Contribution to journal › Article › peer-review
Open AccessFile3 Downloads (Pure) -
Effectiveness and safety of 7-day high-dose primaquine and single-dose tafenoquine versus 14-day low-dose primaquine in patients with Plasmodium vivax malaria (EFFORT): a multicentre, open-label, randomised, controlled, superiority trial
Degaga, T. S., Pasaribu, A. P., Tripura, R., Ghanchi, N., Rajasekhar, M., Adhikari, B., Ley, B., Bamboro, S. A., Jabbar, F. A., Hasibuan, N., Tego, T. T., Zehra, S., Qurashi, B., Mnjala, H., Lee, G., Li, P., Kazi, A. M., Safitri, W., Yulita, Y. & Siagian, D. S. P. & 43 others, , Jun 2026, In: The Lancet Infectious Diseases. 26, 6, p. 614-626 13 p.Research output: Contribution to journal › Article › peer-review
Open AccessFile3 Link opens in a new tab Citations (Scopus)4 Downloads (Pure) -
Effect of higher dose primaquine for the radical cure of Plasmodium vivax malaria in Indonesia: a systematic review and individual patient data meta-analysis
Fadilah, I., Watson, J. A., Pasaribu, A. P., Sutanto, I., Nelwan, E. J., Lidia, K., Rajasekhar, M., Elyazar, I. R., Taylor, W. R., Thriemer, K., Day, N. P., Poespoprodjo, J. R., Simpson, J. A., Price, R. N., Baird, J. K. & Commons, R. J., Jun 2026, In: The Lancet Regional Health - Western Pacific. 72, p. 1-14 14 p., 101908.Research output: Contribution to journal › Article › peer-review
Open AccessFile -
Moving towards high-dose primaquine or single-dose tafenoquine for Plasmodium vivax treatment in Cambodia: a meeting report from dissemination of results of the EFFORT trial to stakeholders
Dysoley, L., Cassidy-Seyoum, S., Adhikari, B., Dahal, A., Phoumen, N., Srey, S., Phalla, T., Vonn, P., Engrkruy, B., Sovanarath, O., Mengkea, H., Rathana, P., Makara, I., Heng, P. K., Heng, Y., Khlok, H., Pong, K., Moeng, T., Vantha, S. & Soviet, U. & 33 others, , Jan 2026, In: Malaria Journal. 25, 1, p. 1-9 9 p., 2.Research output: Contribution to journal › Article › peer-review
Open AccessFile1 Downloads (Pure) -
Predicting Risk of Plasmodium Vivax Microscopy-Detected Episodes Using Serological Markers in Patients With Plasmodium falciparum Malaria: A Multicountry Diagnostic Performance Evaluation
Hafidzah, M., Degaga, T. S., Christian, M., Alam, M. S., Hossain, M. S., Baird, J. K., Sutano, I., Smith, L., Argyropoulos, D. C., Amelia, A. R., Noviyanti, R., Robinson, L. J., Price, R. N., Mueller, I., Thriemer, K. & Longley, R. J., Jun 2026, In: Journal of Infectious Diseases. 233, 6, p. e1470-e1479 10 p.Research output: Contribution to journal › Article › peer-review
Open AccessFile3 Downloads (Pure) -
Risk perceptions of high-dose primaquine and tafenoquine among Plasmodium vivax malaria stakeholders in Ethiopia: a qualitative study
Mwaura, M., Engel, N., Kejela, M., Korra, K. G., Wodaj, T., Shibiru Degaga, T., Ley, B., Price, R., Krumeich, A. & Thriemer, K., Jun 2026, In: BMJ Global Health. 11, 6, p. 1-12 12 p., e021763.Research output: Contribution to journal › Article › peer-review
Open AccessFile
Activities
- 1 Invited talk
-
Improving primaquine treatment for P. vivax malaria
Ley-Thriemer, K. (Invited speaker)
16 Dec 2020Activity: Talk or presentation › Invited talk